These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2264829

  • 1. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.
    Southern C, Schulster D, Green IC.
    Biochem J; 1990 Nov 15; 272(1):243-5. PubMed ID: 2264829
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism.
    Southern C, Schulster D, Green IC.
    FEBS Lett; 1990 Dec 10; 276(1-2):42-4. PubMed ID: 2265709
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
    Sandler S, Bendtzen K, Eizirik DL, Welsh M.
    Endocrinology; 1990 Feb 10; 126(2):1288-94. PubMed ID: 2404746
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
    Sjöholm A.
    FEBS Lett; 1991 Sep 09; 289(2):249-52. PubMed ID: 1655527
    [Abstract] [Full Text] [Related]

  • 5. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
    Kawahara DJ, Kenney JS.
    Cytokine; 1991 Mar 09; 3(2):117-24. PubMed ID: 1888882
    [Abstract] [Full Text] [Related]

  • 6. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S, Bendtzen K, Borg LA, Eizirik DL, Strandell E, Welsh N.
    Endocrinology; 1989 Mar 09; 124(3):1492-501. PubMed ID: 2521822
    [Abstract] [Full Text] [Related]

  • 7. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
    Buscema M, Vinci C, Gatta C, Rabuazzo MA, Vignen R, Purrello F.
    Metabolism; 1992 Mar 09; 41(3):296-300. PubMed ID: 1531861
    [Abstract] [Full Text] [Related]

  • 8. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
    Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML.
    Diabetes; 1987 Aug 09; 36(8):963-70. PubMed ID: 3297891
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets.
    Hughes JH, Easom RA, Wolf BA, Turk J, McDaniel ML.
    Diabetes; 1989 Oct 09; 38(10):1251-7. PubMed ID: 2507377
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.
    Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML.
    J Clin Invest; 1990 Sep 09; 86(3):856-63. PubMed ID: 2203826
    [Abstract] [Full Text] [Related]

  • 11. Effect of recombinant IL-1 isomers on fetal and adult islet cell function and replication.
    Khatim MS, Bahr GM, Gumaa KA, Behbehani K.
    Diabetes Res; 1988 May 09; 8(1):25-9. PubMed ID: 3066563
    [Abstract] [Full Text] [Related]

  • 12. Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta.
    Helqvist S, Polla BS, Johannesen J, Nerup J.
    Diabetologia; 1991 Mar 09; 34(3):150-6. PubMed ID: 1884886
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets.
    Zawalich WS, Diaz VA.
    Diabetes; 1986 Oct 09; 35(10):1119-23. PubMed ID: 3530842
    [Abstract] [Full Text] [Related]

  • 14. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    Corbett JA, Sweetland MA, Lancaster JR, McDaniel ML.
    FASEB J; 1993 Feb 01; 7(2):369-74. PubMed ID: 8440413
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
    Rabuazzo AM, Buscema M, Caltabiano V, Anello M, Degano C, Patanè G, Vigneri R, Purrello F.
    Diabetologia; 1995 Jul 01; 38(7):779-84. PubMed ID: 7556978
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
    Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML.
    Proc Natl Acad Sci U S A; 1993 Mar 01; 90(5):1731-5. PubMed ID: 8383325
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
    Welsh N, Sandler S.
    Biochem Biophys Res Commun; 1992 Jan 15; 182(1):333-40. PubMed ID: 1731791
    [Abstract] [Full Text] [Related]

  • 19. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
    Eizirik DL, Welsh N, Hellerström C.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):399-403. PubMed ID: 8432782
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin.
    Stickings P, Cunningham JM.
    Cytokine; 2002 Apr 21; 18(2):81-5. PubMed ID: 12096922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.